Minagawa Y - Search Results

1

Chemosensitivity and p53-dependent apoptosis in epithelial ovarian carcinoma.

Sato S, Kigawa J, Minagawa Y, Okada M, Shimada M, Takahashi M, Kamazawa S, Terakawa N. Sato S, et al. Among authors: minagawa y. Cancer. 1999 Oct 1;86(7):1307-13. Cancer. 1999. PMID: 10506718

2

Tumor DNA ploidy and prognosis of patients with serous cystadenocarcinoma of the ovary.

Kigawa J, Minagawa Y, Ishihara H, Kanamori Y, Terakawa N. Kigawa J, et al. Among authors: minagawa y. Cancer. 1993 Aug 1;72(3):804-8. doi: 10.1002/1097-0142(19930801)72:3<804::aid-cncr2820720328>3.0.co;2-n. Cancer. 1993. PMID: 8334634

3

Glutathione S-transferase-pi expression and glutathione concentration in ovarian carcinoma before and after chemotherapy.

Cheng X, Kigawa J, Minagawa Y, Kanamori Y, Itamochi H, Okada M, Terakawa N. Cheng X, et al. Among authors: minagawa y. Cancer. 1997 Feb 1;79(3):521-7. Cancer. 1997. PMID: 9028363

4

Glutathione concentration may be a useful predictor of response to second-line chemotherapy in patients with ovarian cancer.

Kigawa J, Minagawa Y, Kanamori Y, Itamochi H, Cheng X, Okada M, Oishi T, Terakawa N. Kigawa J, et al. Among authors: minagawa y. Cancer. 1998 Feb 15;82(4):697-702. doi: 10.1002/(sici)1097-0142(19980215)82:4<697::aid-cncr12>3.0.co;2-t. Cancer. 1998. PMID: 9477102

5

Alteration of telomerase activity associated with development and extension of epithelial ovarian cancer.

Oishi T, Kigawa J, Minagawa Y, Shimada M, Takahashi M, Terakawa N. Oishi T, et al. Among authors: minagawa y. Obstet Gynecol. 1998 Apr;91(4):568-71. doi: 10.1016/s0029-7844(98)00044-1. Obstet Gynecol. 1998. PMID: 9540942

6

Gamma-glutamyl cysteine synthetase up-regulates glutathione and multidrug resistance-associated protein in patients with chemoresistant epithelial ovarian cancer.

Kigawa J, Minagawa Y, Cheng X, Terakawa N. Kigawa J, et al. Among authors: minagawa y. Clin Cancer Res. 1998 Jul;4(7):1737-41. Clin Cancer Res. 1998. PMID: 9676849

7

A newly developed adenovirus-mediated transfer of a wild-type p53 gene increases sensitivity to cis-diamminedichloroplatinum (II) in p53-deleted ovarian cancer cells.

Kanamori Y, Kigawa J, Minagawa Y, Irie T, Oishi T, Shimada M, Takahashi M, Nakamura T, Sato K, Terakawa N. Kanamori Y, et al. Among authors: minagawa y. Eur J Cancer. 1998 Oct;34(11):1802-6. doi: 10.1016/s0959-8049(98)00199-3. Eur J Cancer. 1998. PMID: 9893672

8

Topoisomerase-I activity and response to second-line chemotherapy consisting of camptothecin-11 and cisplatin in patients with ovarian cancer.

Kigawa J, Takahashi M, Minagawa Y, Oishi T, Sugiyama T, Yakushiji M, Terakawa N. Kigawa J, et al. Among authors: minagawa y. Int J Cancer. 1999 Oct 22;84(5):521-4. doi: 10.1002/(sici)1097-0215(19991022)84:5<521::aid-ijc13>3.0.co;2-x. Int J Cancer. 1999. PMID: 10502731

9

Cisplatin-resistant HeLa cells are resistant to apoptosis via p53-dependent and -independent pathways.

Minagawa Y, Kigawa J, Itamochi H, Kanamori Y, Shimada M, Takahashi M, Terakawa N. Minagawa Y, et al. Jpn J Cancer Res. 1999 Dec;90(12):1373-9. doi: 10.1111/j.1349-7006.1999.tb00722.x. Jpn J Cancer Res. 1999. PMID: 10665656 Free PMC article.

10

Alteration of a p53 gene status affects outcome of patients with recurrent ovarian cancer.

Irie T, Kigawa J, Minagawa Y, Oishi T, Takahashi M, Shimada M, Kamazawa S, Sato S, Terakawa N. Irie T, et al. Among authors: minagawa y. Oncology. 2000 Apr;58(3):237-41. doi: 10.1159/000012106. Oncology. 2000. PMID: 10765126

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

220 results

Search Page

Filters